We are seeking approximately 100 participants to take part in a 12-week study evaluating the effectiveness of Qualia Magnesium+, a dietary supplement designed to potentially support magnesium levels, sleep quality, and stress reduction.
This is a randomized, double-blind, placebo-controlled study, meaning participants will be randomly assigned to receive either Qualia Magnesium+ or a placebo, and neither participants nor researchers will know which study product was received until after the study ends.
Participants will take 2 capsules daily in the evening, with or without food, for 12 weeks. The study will involve regular check-ins, self-report questionnaires, and blood tests conducted at a local facility (such as Quest Diagnostics) to measure red blood cell (RBC) and serum magnesium levels.
Upon completion of the study, participants will receive a $300 credit at Qualia Life Sciences.
Participation Requirements:
Healthy adults 21 years or older
Can read and write English
Agree to provide a valid cell phone number and are willing to receive communications through text
Willing to not consume any supplements containing magnesium starting about 2 weeks prior to the baseline magnesium blood test and continuing through the intervention period.
Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly with the exception of those containing magnesium
Willing to complete questionnaires, records, and diaries associated with the study.
Willing to visit a local blood draw facility (must live within 20 miles of one)
Willing to pause any magnesium-containing supplements during the study period
Exclusion Criteria:
Women who are pregnant, breastfeeding or planning to become pregnant during the trial
Known food intolerances/allergy to any ingredients in the product
Having any of the following conditions: Psychiatric conditions, neurologic disorders, high blood pressure, heart conditions, endocrine disorders, or cancer
Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
This study is being conducted by Qualia Life Science